Avantor, Inc. (AVTR)

NYSE: AVTR · Real-Time Price · USD

8.17

-0.35 (-4.11%)

At close: Mar 6, 2026, 4:00 PM

8.11

-0.06 (-0.73%)

Pre-market: Mar 9, 2026, 3:00 AM EST

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Laboratory Solutions Revenue	4.40B	4.61B
Laboratory Solutions Revenue Growth	-4.56%	-2.71%
Bioscience Production Revenue	2.15B	2.17B
Bioscience Production Revenue Growth	-0.97%	-2.49%
Revenue (Total)	6.55B	6.78B
Revenue (Total) Growth	-3.41%	-2.63%

Adjusted EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Laboratory Solutions Adjusted Operating Income	510.40M	598.00M
Laboratory Solutions Adjusted Operating Income Growth	-14.65%	-10.52%
Bioscience Production Adjusted Operating Income	517.80M	558.20M
Bioscience Production Adjusted Operating Income Growth	-7.24%	-7.26%
Corporate Adjusted Operating Income	-70.40M	-66.40M
Operating Income (Total)	-246.20M	1.08B
Operating Income (Total) Growth	-	55.77%

Updated Feb 11, 2026. Data Source: Fiscal.ai.